Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-04-09 3:07 pm Purchase |
2021-04-09 | 13G | Olo Inc. OLO |
Capital Research Global Investors | 3,420,000 16.500% |
3,420,000![]() (New Position) |
Filing History |
2021-03-10 11:42 am Purchase |
2021-03-10 | 13G | Burlington Stores, Inc. BURL |
Capital Research Global Investors | 6,626,338 10.000% |
187,933![]() (+2.92%) |
Filing History |
2021-03-10 11:42 am Sale |
2021-03-10 | 13G | GW PHARMACEUTICALS PLC GWPH |
Capital Research Global Investors | 16,701,517 4.500% |
-28,132,995![]() (-62.75%) |
Filing History |
2021-03-10 11:39 am Sale |
2021-03-10 | 13G | bluebird bio, Inc. BLUE |
Capital Research Global Investors | 0 0.000% |
-627,504![]() (Position Closed) |
Filing History |
2021-02-16 5:32 pm Purchase |
2021-02-16 | 13G | XP Inc. XP |
Capital Research Global Investors | 19,672,524 5.200% |
19,672,524![]() (New Position) |
Filing History |
2021-02-16 5:29 pm Purchase |
2021-02-16 | 13G | StoneCo Ltd. STNE |
Capital Research Global Investors | 29,189,624 12.900% |
29,189,624![]() (New Position) |
Filing History |
2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | Baker Hughes Company BKR |
Capital Research Global Investors | 73,160,709 10.700% |
7,271,230![]() (+11.04%) |
Filing History |
2021-02-16 3:58 pm Sale |
2021-02-16 | 13G | Bandwidth Inc. BAND |
Capital Research Global Investors | 518,400 2.300% |
-798,401![]() (-60.63%) |
Filing History |
2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | Principal Financial Group, Inc. PFG |
Capital Research Global Investors | 15,934,119 5.800% |
1,659,369![]() (+11.62%) |
Filing History |
2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | Revvity, Inc. RVTY |
Capital Research Global Investors | 12,173,992 10.900% |
318,750![]() (+2.69%) |
Filing History |
2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | Paya Holdings Inc. PAYA |
Capital Research Global Investors | 6,867,000 5.900% |
6,867,000![]() (New Position) |
Filing History |
2021-02-16 3:58 pm Sale |
2021-02-16 | 13G | Constellation Brands, Inc. STZ |
Capital Research Global Investors | 7,325,335 4.300% |
-1,771,194![]() (-19.47%) |
Filing History |
2021-02-16 3:58 pm Sale |
2021-02-16 | 13G | Melco Resorts & Entertainment Limited MLCO |
Capital Research Global Investors | 88,307,793 6.200% |
-23,973,297![]() (-21.35%) |
Filing History |
2021-02-16 3:58 pm Sale |
2021-02-16 | 13G | Qorvo, Inc. QRVO |
Capital Research Global Investors | 2,734,670 2.400% |
-4,412,585![]() (-61.74%) |
Filing History |
2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | PRA HEALTH SCIENCES INC PRAH |
Capital Research Global Investors | 3,450,676 5.400% |
874,690![]() (+33.96%) |
Filing History |
2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | Penumbra, Inc. PEN |
Capital Research Global Investors | 3,248,192 8.900% |
3,248,192![]() (New Position) |
Filing History |
2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | Broadcom Inc. AVGO |
Capital Research Global Investors | 331,248,860 8.100% |
44,763,310![]() (+15.62%) |
Filing History |
2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | Burlington Stores, Inc. BURL |
Capital Research Global Investors | 6,438,405 9.700% |
6,438,405![]() (New Position) |
Filing History |
2021-02-16 3:58 pm Sale |
2021-02-16 | 13G | BWX Technologies, Inc. BWXT |
Capital Research Global Investors | 3,102,844 3.300% |
-3,724,583![]() (-54.55%) |
Filing History |
2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Capital Research Global Investors | 130,140,247 11.900% |
130,140,247![]() (New Position) |
Filing History |